Neuroprotective effects of combined trimetazidine and progesterone on cerebral reperfusion injury.
Curr Res Pharmacol Drug Discov
; 3: 100108, 2022.
Article
en En
| MEDLINE
| ID: mdl-35602337
ABSTRACT
Cerebral ischemia-reperfusion injury induces multi-dimensional damage to neuronal cells through exacerbation of critical protective mechanisms. Targeting more than one mechanism simultaneously namely, inflammatory responses and metabolic energy homeostasis could provide additional benefits to restrict or manage cerebral injury. Being proven neuroprotective agents both, progesterone (PG) and trimetazidine (TMZ) has the potential to add on the individual therapeutic outcomes. We hypothesized the simultaneous administration of PG and TMZ could complement each other to synergize, or at least enhance neuroprotection in reperfusion injury. We investigated the combination of PG and TMZ on middle cerebral artery occlusion (MCAO) induced cerebral reperfusion injury in rats. Molecular docking on targets of energy homeostasis and apoptosis assessed the initial viability of PG and TMZ for neuroprotection. Animal experimentation with MCA induced ischemia-reperfusion (I/R) injury in rats was performed on five randomized groups. Sham operated control group received vehicle (saline) while the other four I-R groups were pre-treated with vehicle (saline), PG (8 âmg/kg), TMZ treated (25 âmg/kg), and PG â+ âTMZ (8 and 25 âmg/kg) for 7 days by intraperitoneal route. Neurological deficit, infarct volume, and oxidative stress were evaluated to assess the extent of injury in rats. Inflammatory reactivity and apoptotic activity were determined with alterations in myeloperoxidase (MPO) activity, blood-brain barrier (BBB) permeability, and DNA fragments. Reperfusion injury inflicted cerebral infarct, neurological deficit, and shattered BBB integrity. The combination treatment of PG and TMZ restricted cellular damage indicated by significant (p â< â0.05) decrease in infarct volume and improvement in free radical scavenging ability (SOD activity and GSH level). MPO activity and LPO decreased which contributed in improved BBB integrity in treated rats. We speculate that inhibition of inflammatory and optimum energy utilization would critically contribute to observed neuroprotection with combined PG and TMZ treatment. Further exploration of this neuroprotective approach for post-recovery cognitive improvement is worth investigating.
3-KAT, 3-Ketoacyl coenzyme A thiolase; AQP4, Aquaporin; Apaf-1, Apoptotic protease activating factor-1; Apoptosis; BBB, Blood brain barrier; CAT, Catalase; DTNB, 5-,5-dithiobis 2-nitrobenzoic acid; FFA, Free fatty acid; GSH, Reduced glutahione; I/R, Ischemia-reperfusion; IL-1ß, Interleukin 1beta; Ischemia-reperfusion; MCAO, Middle cerebral artery occlusion; MDA, Malondialdehyde; MPO, Myeloperoxidase; Metabolic energy; Molecular docking; Myeloperoxidase; Oxidative stress; PG, Progesterone; ROCK, Rho/Rho-kinase; SOD, Superoxide dismutase; TBA, Thiobarbituric acid; TCA, Trichloroacetic acid; TMZ, Trimetazidine; TNFα, Tumor necrosis factor-alpha; TTC, 2,3,5-triphenyl-tetrazolium chloride; mptp, Mitochondrial pore permeability
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
Idioma:
En
Año:
2022
Tipo del documento:
Article